ANI Pharmaceuticals, Inc. (ANIP)
73.25
+0.42
(+0.58%)
USD |
NASDAQ |
Aug 31, 16:00
73.34
+0.09
(+0.12%)
After-Hours: 20:00
ANI Pharmaceuticals Cash from Operations (Annual) : 185.22M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 185.22M |
| December 31, 2024 | 64.02M |
| December 31, 2023 | 118.96M |
| December 31, 2022 | -31.20M |
| December 31, 2021 | 3.322M |
| December 31, 2020 | 15.27M |
| December 31, 2019 | 45.63M |
| December 31, 2018 | 65.50M |
| December 31, 2017 | 39.42M |
| December 31, 2016 | 27.47M |
| December 31, 2015 | 17.26M |
| December 31, 2014 | 22.03M |
| December 31, 2013 | -5.484M |
| December 31, 2012 | -25.28M |
| Date | Value |
|---|---|
| December 31, 2011 | -47.87M |
| December 31, 2010 | -40.10M |
| December 31, 2009 | -18.43M |
| December 31, 2008 | -15.54M |
| December 31, 2007 | 0.74M |
| December 31, 2006 | -4.997M |
| December 31, 2005 | -8.298M |
| December 31, 2004 | -10.44M |
| December 31, 2003 | -5.522M |
| December 31, 2002 | -3.962M |
| December 31, 2001 | -1.824M |
| December 31, 2000 | -3.208M |
| December 31, 1999 | -1.788M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viatris, Inc. | 2.316B |
| Liquidia Corp. | -35.69M |
| Elanco Animal Health, Inc. | 560.00M |
| Harmony Biosciences Holdings, Inc. | 348.20M |
| Corcept Therapeutics, Inc. | 142.00M |